SUMMARY
INTRODUCTION
Understanding of the eukaryotic cell cycle has been revolu tionized by the discovery that all of the major regulatory points are controlled by a class of protein kinases known as cyclindependent kinases, or Cdks (for reviews see Sherr, 1993; Reed, 1992; Pines and Hunter, 1991) . The functional paradigm of these kinases is that they are composed of a catalytic subunit that has no intrinsic activity and a requisite positive regulatory subunit known as a cyclin. In simple eukaryotic organisms such as yeast, a single Cdk catalytic subunit interacts with numerous different classes of cyclin to mediate diverse cell cycle phase transitions. In mammalian cells, the regulatory environment is complicated by the presence of multiple Cdks (Meyerson et al., 1992) as well as cyclins Lew and Reed, 1992) . It has been our goal to elucidate the roles of these kinases and cyclins in the regulation of the Gi to S phase transition.
RESULTS AND DISCUSSION

Gi cyclins
A number of lines of evidence implicate three types of cyclin in Gi and S phase functions. Cyclins D1 and E were identified on the basis of their ability to rescue a deficiency of Gi cyclin function in the simple eukaryote yeast (Lew et al., 1991; Koff et al., 1991) . At the same time, the cyclin D1 cDNA was isolated on the basis of the growth factor inducibility of the corresponding mRNA (Matsushime et al., 1991) and because of its location at a chromosomal breakpoint associated with malignancy (Motokura et al., 1991; Withers et al., 1991) .
After the identification of cyclin D l, two other closely related cyclins, D2 and D3, were identified on the basis of their homology to cyclin D l (Matsushime et al., 1991) . Patterns of expression suggested that cyclins D and E were associated with Gi and/or Gi/S phase functions Koff et al., 1992; Baldin et al., 1993; Won et al., 1992) . Finally, cyclin A, shown to accumulate beginning at the Gi/S phase boundary, was suggested to have a potential role during S phase (Pines and Hunter, 1990) .
Several lines of evidence confirm Gi or Gi/S phase roles for these three classes of cyclin. Antibody microinjection experi ments using IgGs specific for cyclins A and D l have demon strated that these cyclins are required for initiation or progres sion through S phase (Girard et al., 1991; Pagano et al., 1992; Zindy et al., 1992; Baldin et al., 1993; Quelle et al., 1993) . Similar experiments using cyclin E-specific antibodies have been unsuccessful, possibly for technical reasons (G. Mondesert and S. Reed, unpublished) . However, cyclin E has been shown to be essential for entry into S phase in Drosophila (Knoblich et al., 1994) , suggesting an essential S phase initiation function in mammalian cells as well. Conversely, constitutive expression of these three cyclins can lead to premature entry into S phase, suggesting that they control functions that are rate-limiting for passage through Gi into S phase (Ohtsubo and Roberts, 1993; Quelle et al., 1993; Resnitzky et al., 1994; D. Resnitzky and S. Reed, unpublished ;  Table 1 ). However, expression of no cyclin alone appears to be able to advance the Gi/S phase to the degree that Gi can be eliminated. This suggests either that several individual ratelimiting transitions within Gi are controlled by different cyclins or that compartments exist within the Gi interval that cannot be influenced by the action of cyclin-dependent kinases. The percentage of Gi cells in asynchronous populations was determined by flow cytometric analysis and was used with the population doubling time to determine the length of the Gi phase. The relative lengths of Go/Gi in populations emerging from quiescence was determined by direct measurement using flow cytometric analysis to monitor entry into S phase. In all experiments, comparisons were based on cultures growing in the presence of tetracycline (cyclins repressed) versus in the absence of tetracycline (cyclins repressed) (Resnitzky et al., 1994) . Clones D5 and D3 are Rati fibroblasts expressing human cyclin D1 and clones E2 and E19 express human cyclin E.
It is o f interest to note that w hereas constitutive expression of cyclins D 1 and E have a m ore profound effect on advance of S phase in cells em erging from quiescence as com pared to cycling cells, expression o f cyclin E confers an equivalent S phase advance in either circum stance, suggesting participation in distinct pathw ays (Resnitzky et al., 1994 ; T able 1).
Finally, w ith the dem onstration that m am m alian cells contain a num ber o f different Cdk catalytic subunits, it was im portant to establish w hich com binations o f Gi cyclins and catalytic subunits contribute to the activities described above. A lthough a large num ber o f com binatorial possibilities have been detected, the biologically critical com plexes for G i/Sphase functions appear to be cyclins A and E com bined w ith catalytic subunit Cdk2 (Pines and Hunter, 1990; D ulic et al., 1992; K off et al., 1992) and D type cyclins com bined with C dk4 (M atsushim e et al., 1992; see Fig. 1 ).
Targets of cyclin-dependent kinase action
O f all the potential targets for the Gi cyclin-dependent kinases, the retinoblastom a susceptibility gene product, pRb is the one m ost often invoked to explain regulation o f the G |/S phase transition. It is know n that pRb inhibits cell cycle progression w hen in a hypophosphorylated form and that phosphorylation reverses these inhibitory functions (Buchkovich et al., 1989; Chen et al., 1989; D eC aprio et al., 1992; Ludlow et al., 1993; M ihara et al., 1989) . A m ounting body o f evidence suggests that the inhibitory function o f pRb is based on the ability of hypophosphorylated pRb to sequester som e m em bers o f a fam ily o f essential transcription factors know n together as E2F (Helin et al., 1992; K aelin et al., 1992; N evins, 1992) . Phos phorylation o f pRb is thought to lead to the release o f tran scription-com petent E2F. Furtherm ore, the in vivo phosphory lation sites on pRb correspond to C dk consensus phosphorylation sites and a variety o f Cdks have been show n to be capable o f phosphorylating pRb in vitro (Lees et al., 1991; Lin et al., 1991 ; K ato e ta l., 1993). T he m ost com pelling evidence for an in vivo role for Cdks in pRb phosphorylation com es from experim ents in SA O S-2 osteosarcom a cells w here ectopic expression o f pRb caused Gi arrest but co-expression o f pRb with either cyclin D, E or A did not (Hinds et al., 1992; Ew en et al., 1993) . It could be show n that, concom itant with the release from Gi arrest, pRb becam e hyperphosphorylated. T hese data suggest that all o f the proposed G i and G i/S phase C dk activities have the capacity to phosphorylate pR b directly or to stim ulate its phosphorylation by other protein kinases in vivo. T hese experim ents have the caveat, how ever, that both pR b and cyclins are highly overexpressed, perhaps im buing them with abnorm al properties. Therefore the issue o f w hich Cdks (cyclins and catalytic subunits) actually contribute to pRb phosphorylation under norm al cellular grow th circum stances rem ains to be resolved. It is notew orthy that D -type cyclins contain m otifs that allow them to bind directly to pRb, pre sum ably facilitating the direction o f kinase activity tow ard this potential substrate (Ew en et al., 1993; D ow dy et al., 1993) .
Several other proteins w ith Rb-like physical proterties have been identified, p i 07 and p i 30 have structural hom ology with pRb, can bind viral oncoproteins, as can pRb, and can bind E 2F as w ell (Ew en et al., 1991; H annon et al., 1993) . H ow ever the relationship o f these proteins to cell cycle control is less w ell understood than that o f pRb. High levels o f expression o f p i 07 in som e cell types confer Gi arrest, suggesting an inhibitory role sim ilar to that o f pRb (Zhu et al., 1993) . T he relationship o f cell cycle control to sequestration o f E 2F is less clear. A lthough p i 07 and p i 30 bind E2F, it appears that different isoform s are involved relative to pRb . The roles o f these isoform s have not yet been elucidated nor has the relationship betw een phosphorylation o f p i 07 and p i 30 and release o f E2F. H ow ever, it has been show n that cyclin The functions of p53 and p21 in mediating cell cycle control in response to DNA damage. DNA damage incurred from external sources such as ionizing radiation (IR) or internal sources, such as the transition to senescence, leads to elevation o f p53 levels. p53 promotes elevated expression of p21, which in turn inhibits Gi Cdks. This ultimately has the effect of inhibiting functions essential for S phase, notably the the release o f E2F isoforms from antagonists such as pRb and p i 07. E/Cdk2 is included in pl07/E2F complexes in late Gi and early S phase whereas cyclin A/Cdk2 is in similar complexes during S phase and G2 . This suggests a regulatory role for cyclin E and cyclin A in regulation of p i 07 functions. If pl07 functions analogously to pRb, then cyclin E/Cdk2 may control release of E2F isoforms associated with p i07 by direct phosphorylation of p i07. Other potential targets of Gi Cdks are proteins directly involved in initiation of DNA replication, such as origin binding proteins. However, these remain to be identified before this idea can be explored.
The Role(s) of Cdk inhibitors
In budding yeast, developmental control of the cell cycle occurs at Gi and is implemented at the level of controlling Gispecific Cdks (Reed, 1992) . Therefore, investigation of Gi control in mammalian cells has focused on Gi Cdks, as well (Sherr, 1993) . Several model systems have been explored including the effects of DNA damage , negative growth factors (Koff et al., 1993; Polyak et al., 1994; Slingerland et al., 1994) , antiproliferative drugs and growth factor deprivation Hengst et al., 1994; Polyak et al., 1994; Slingerland et al., 1994) . A common theme has emerged, namely that Gi control in response to a variety of signals is mediated at the level of proteins that inhibit the kinase activities of Cdks via stoichio metric binding Hengst et al., 1994; Polyak et al., 1994; Slingerland et al., 1994) .
When human diploid fibroblasts are synchronized by growth to confluence followed by replating, they can be prevented from entering S phase by high doses of ionizing radiation such as y-rays (Little and Nagasawa, 1985) . Unirradiated cells enter S phase at approximately 18 hours after release from contact inhibition. Cells blocked in Gi were found to accumulate normal levels of cyclin E and D1 and to form normal levels of cyclin E/Cdk2 and cyclin Dl/Cdk4 complexes. However, these complexes were found not to be active . It was shown that cyclin/Cdk complexes under these conditions contained a heat stable Cdk inhibitory protein whose presence was dependent on the wild-type status of the tumor suppressor p53. Further investigation indicated that this inhibitor corre sponded to p21 Wafl/ClP1 (El-Deiry et al., 1993; Harper et al., 1993; Xiong et al., 1993; Gu et al., 1993) , shown to be a p53-inducible Cdk inhibitor . These data establish a p53-dependent signal transduction pathway linking DNA damage to cell cycle control (Fig. 2) . The loss of genome stability in response to negation of p53 function is likely to arise from the uncoupling of cell cycle control from DNA damage responses. This is likely to be an important modality in the transition to malignancy. Similar data have been obtained for senescent fibroblasts (Dulic et al., 1993) where DNA damage signals have been invoked to explain the block to proliferation.
The response of epithelial cells to epithelial antiproliferative agent, TGF-P, is phenomenologically similar to the response to DNA damage. In human breast epithelial cells presynchro nized by growth factor depletion and refeeding, and then treated with TGF-P, cyclin E accumulates on schedule, asso ciates with Cdk2, but cyclin/Cdk complexes are inactive . Similarly, in the situation with ionizing radiation, a heat stable Cdk inhibitor could be detected in lysates from TGF-p treated cells E. Bailly and S. Reed, unpublished) . However it is unlikely that this inhibitor is p 2 1 W afl/c'P 1. Similar studies on mink lung epithelial cells suggest that the inhibitor induced by treatment with TGF-p is a 27/28 kDa protein that is distinct from p21 (Polyak et al., 1994) . This protein has been alternately desig nated p27KlP1 and p28Ickl. p27/p28 accumulates under a number of conditions associ ated with Gi arrest of the cell cycle (Fig. 3) . HeLa cells treated with the drug lovastatin, which confers Gi arrest, accumulate p27/p28 in inactive cyclin/Cdk complexes . Since p27/p28 is heat stable, it can be released from these complexes by boiling. p27/p28 also accumulates in fibroblasts and epithelial cells deprived of essential growth factors . It has also been shown to fluctuate through the cell cycle in proliferating cells, with maximal levels in mid-Gi . Finally, like p21, it has been shown to have the ability to bind and inhibit a broad spectrum of Cdks . These data suggest that a variety of conditions that confer Gi arrest in mammalian cells lead to the production or maintenance of a Cdk inhibitor, p27/p28 that has the capacity to arrest the cell cycle in Gi. In addition, this inhibitor fluctuates through the cell cycle, pre sumably to prevent premature activation of Cdks during the Gi interval. Finally, p27/p28 and p21 appear to play complemen tary roles in cell cycle control mediating the antiproliferative responses associated with distinct signals. In particular, p21 seems to be associated with responses to DNA damage, whereas p27/p28 appears to mediate a more general antipro liferative response.
In summary, the primary motif of cell cycle regulation in Gi appears to be through the action of cell cycle inhibitory proteins that bind to and inhibit Cdks by a stoichiometric mechanism. This is distinct from control of the G2/M phase transition, which is mediated primarily at the level of negative phosphorylation of the Cdkl catalytic subunit (Gould and Nurse, 1989) . One possible reason for the prevalence of broad spectrum Cdk inhibitors in Gi control is that it would allow coordinate control of several distinct Cdks thought to collabo rate in progression through Gi to S phase. It is not yet clear whether p21 and p27/p28 define all of the Cdk inhibitors involved in cell cycle control or whether they are only the first members of a larger family to be identified.
